NCT05092594Unknown不适用
The Prognostic Value of IgM in Covid-19 Infection
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 500
- 主要终点
- Ventilation
研究概览
简要总结
The primary objective of the research is to study the relation between the presence and /or the anti SARS-Co-V-2 IgM level in an early stage of COVID-19 infection, and the evolution of the illness.
详细描述
The secondary objective is to determinate in what manner response of IgM anti-SARS-Co-V-2 relates to patient's immunity statute, in regards to the other so-called humain "seasonal coronavirus".
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients ≥ 18 years;
- •Have been diagnosed positive of SARS-CoV-2 in the Virological Laboratory of Ambroise Paré hospital;
- •Have been blood sampled between 1 day and 14 days from the first clinical syndromes, and their collections of serum or plasma are conserved and accessible;
- •Affiliated to the social security scheme or entitled;
- •Informed and non-opposed to participating to the study.
排除标准
- •Opposition of patient to participation to the study;
- •Foreign patients under french AME scheme.
结局指标
主要结局
Ventilation
时间窗: through study completion, an average of 1 month
Non ventilation versus ventilation during Covid-19 hospitalization
Hospitalization
时间窗: through study completion, an average of 1 month
Absence of hospitalization versus hospitalization without ventilation during SARS-CoV-2 infection
次要结局
- Ventilation(through study completion, an average of 1 month)
- Hospitalization at Ambroise Paré hospital(through study completion, an average of 1 month)
- IgM anti-SARS-Co-V-2 presence(through study completion, an average of 1 month)
- Oxygenotherapy(through study completion, an average of 1 month)
- Thoracic CT(through study completion, an average of 1 month)
- Patient's vital statute(through study completion, an average of 1 month)
研究者
相似试验
已完成
不适用
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology AssaysCovid19NCT04562285Henry Ford Health System829
Unknown
不适用
PAI-1 Levels and Predicting Covid-19 Patients' PrognosisCovid-19 Positivity Confirmed With PCR Positivity in the Nasopharyngeal SwabSymptomatic Covid -19 Positive Patients Who Require HospitalizationPatients Who Did Not Vaccinate Against Covid-19Patients Among 20 to 90 Years of AgeHealthy Control Patients of the Same AgeNCT04997928Saglik Bilimleri Universitesi80
Unknown
4 期
Immunogenicity Study of the Covid-19 (Recombinante) Vaccine With a 4 or 8 Week Interval Between the First Doses.COVID-19NCT05157178The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)1,264
已完成
不适用
A Prospective Virtual Study to Evaluate the Longevity of IgG Antibodies in Individuals Exposed to COVID-19SARS-CoV-2 Acute Respiratory DiseaseNCT05042193Everly Health1,883
终止
2 期
ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)COVID-19Severe Acute Respiratory Syndrome (SARS)Coronavirus InfectionsNCT04432272William Beaumont Hospitals71